+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Peripheral Vascular Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 409 Pages
  • January 2024
  • Region: Global
  • Fairfield Market Research
  • ID: 5924996
The global peripheral vascular devices market is on an upward trajectory, projected to propel it to a valuation of US$ 8.6 billion by the end of 2031, according to the latest report. In 2024, the market generated revenues of US$ 4.9 billion, with peripheral vascular stents accounting for a substantial portion.

Increased Volume of Surgeries & Accessibility to Reimbursements Driving Growth

One of the key factors driving the expansion of the peripheral vascular devices market is the increasing volume of surgeries and improved access to reimbursements. The rise in outpatient procedures for peripheral vascular interventions, particularly in developed countries, is attributed to modifications in reimbursement policies and government initiatives. This trend is expected to continue, fostering market growth.

Rising Number of End Users Fueling Market Expansion

The market is further buoyed by the growing number of ambulatory surgical centers (ASCs) in both underdeveloped and developing nations. The proliferation of ASCs is expected to lead to an increase in outpatient cases, thereby driving overall market expansion.

Challenges Due to Product Recalls

While the peripheral vascular devices market is on an upward trajectory, challenges exist, including an increasing threat of product recalls. The development of new and innovative technologies has led to some products being recalled by regulatory bodies like the Food and Drug Administration (FDA) due to serious adverse health consequences. Factors such as deployment issues, bleeding, and strokes pose potential risks and may restrain market growth to some extent.

Country-wise Insights: The U.S., Germany, and China

  • The Lucrative U.S. Market: The United States accounted for 94.5% of the North American peripheral vascular devices market. The U.S. market benefits from ongoing development, innovation in technology, and the growing use of drug-eluting stents in interventional procedures.
  • Germany's Stance: Germany held a significant share in the European peripheral vascular devices market. The country's focus on research and development, coupled with its quick adoption of healthcare technologies, positions it as a prominent player in the market.
  • China Emerges Strong: China dominated the East Asia peripheral vascular devices market. The rising prevalence of diabetes and an aging population in China are driving the demand for peripheral vascular devices.

Competitive Analysis and Key Players

Leading manufacturers in the peripheral vascular devices industry are actively developing technologically-advanced products to strengthen their global portfolios. Mergers, acquisitions, expansions, and collaborations are common strategies employed by key players to enhance their market share.

Key Companies Profiled:

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Cook Medical Inc.
  • MicroPort Scientific Corporation (Endovastec™)
  • Medtronic Plc.
  • Cardinal Health, Inc.
  • B. Braun Melsungen AG
  • BIOTRONIK SE & Co. KG
  • Becton, Dickinson and Company
  • W. L. Gore & Associates Inc.
  • Getinge AB
  • Terumo Corp
  • Kyoto Medical Planning Co Ltd
  • iVascular S.L.U
  • AMG International GmbH
  • ENDOCOR GmbH
  • Meril Life Sciences Pvt. Ltd.
  • Nano Therapeutics Pvt Ltd
  • Koninklijke Philips N.V.
  • REVA Medical

Peripheral Vascular Devices Industry Research Segmentation

By Product:

  • Peripheral Vascular Stents
  • Self-Expanding Stents
  • Balloon Expanding Stents
  • Covered Stents
  • Drug Eluting Stents
  • Drug Eluting Balloons
  • Peripheral Vascular Bioresorbable Scaffolds

By Indication:

  • Target Artery Instability (TAI)
  • Access Artery Injury (AAI)
  • Peripheral Arterial Disease
  • Arteriovenous Fistulas
  • Peripheral Aneurysms
  • Others

By Artery Type:

  • Carotid Artery
  • Fem-Pop Artery
  • Iliac Artery
  • Infrapop Artery

By End User:

  • Hospitals
  • Ambulatory Surgical Centers/Outpatients
  • Cardiac Catheterization Labs

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Peripheral Vascular Devices Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Production Output and Trade Statistics, 2018 - 2023
3.1. Global Peripheral Vascular Devices Market Production Output, by Region, Value (US$ Bn) and Volume (Units), 2018 - 2023
3.1.1. North America
3.1.2. Europe
3.1.3. Asia Pacific
3.1.4. Latin America
3.1.5. Middle East and Africa
4. Price Analysis, 2018 - 2023
4.1. Global Average Price Analysis, by Product/ Material, US$ Per Unit, 2018 - 2023
4.2. Prominent Factor Affecting Peripheral Vascular Devices Prices
4.3. Global Average Price Analysis, by Region, US$ Per Unit
5. Global Peripheral Vascular Devices Market Outlook, 2018 - 2031
5.1. Global Peripheral Vascular Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Peripheral Vascular Stents
5.1.1.1.1. Self-Expanding Stents
5.1.1.1.2. Balloon Expanding Stents
5.1.1.1.3. Covered Stents
5.1.1.1.4. Drug Eluting Stents
5.1.1.2. Drug Eluting Balloons
5.1.1.3. Peripheral Vascular Bioresorbable Scaffolds
5.2. Global Peripheral Vascular Devices Market Outlook, by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Target Artery Instability (TAI)
5.2.1.2. Access Artery Injury (AAI)
5.2.1.3. Peripheral Arterial Disease
5.2.1.4. Arteriovenous Fistulas
5.2.1.5. Peripheral Aneurysms
5.2.1.6. Others
5.3. Global Peripheral Vascular Devices Market Outlook, by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Carotid Artery
5.3.1.2. Fem-Pop Artery
5.3.1.3. Iliac Artery
5.3.1.4. Infrapop Artery
5.4. Global Peripheral Vascular Devices Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
5.4.1. Key Highlights
5.4.1.1. Hospitals
5.4.1.2. Ambulatory Surgical Centers/Outpatients
5.4.1.3. Cardiac Catheterization Labs
5.5. Global Peripheral Vascular Devices Market Outlook, by Region, Value (US$ Bn) and Volume (Units), 2018 - 2031
5.5.1. Key Highlights
5.5.1.1. North America
5.5.1.2. Europe
5.5.1.3. Asia Pacific
5.5.1.4. Latin America
5.5.1.5. Middle East & Africa
6. North America Peripheral Vascular Devices Market Outlook, 2018 - 2031
6.1. North America Peripheral Vascular Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Peripheral Vascular Stents
6.1.1.1.1. Self-Expanding Stents
6.1.1.1.2. Balloon Expanding Stents
6.1.1.1.3. Covered Stents
6.1.1.1.4. Drug Eluting Stents
6.1.1.2. Drug Eluting Balloons
6.1.1.3. Peripheral Vascular Bioresorbable Scaffolds
6.2. North America Peripheral Vascular Devices Market Outlook, by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Target Artery Instability (TAI)
6.2.1.2. Access Artery Injury (AAI)
6.2.1.3. Peripheral Arterial Disease
6.2.1.4. Arteriovenous Fistulas
6.2.1.5. Peripheral Aneurysms
6.2.1.6. Others
6.3. North America Peripheral Vascular Devices Market Outlook, by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. Carotid Artery
6.3.1.2. Fem-Pop Artery
6.3.1.3. Iliac Artery
6.3.1.4. Infrapop Artery
6.4. North America Peripheral Vascular Devices Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
6.4.1. Key Highlights
6.4.1.1. Hospitals
6.4.1.2. Ambulatory Surgical Centers/Outpatients
6.4.1.3. Cardiac Catheterization Labs
6.5. North America Peripheral Vascular Devices Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
6.5.1. Key Highlights
6.5.1.1. U.S. Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
6.5.1.2. U.S. Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
6.5.1.3. U.S. Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
6.5.1.4. U.S. Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
6.5.1.5. Canada Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
6.5.1.6. Canada Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
6.5.1.7. Canada Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
6.5.1.8. Canada Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
6.5.2. BPS Analysis/Market Attractiveness Analysis
7. Europe Peripheral Vascular Devices Market Outlook, 2018 - 2031
7.1. Europe Peripheral Vascular Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Peripheral Vascular Stents
7.1.1.1.1. Self-Expanding Stents
7.1.1.1.2. Balloon Expanding Stents
7.1.1.1.3. Covered Stents
7.1.1.1.4. Drug Eluting Stents
7.1.1.2. Drug Eluting Balloons
7.1.1.3. Peripheral Vascular Bioresorbable Scaffolds
7.2. Europe Peripheral Vascular Devices Market Outlook, by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.2.1. Key Highlights
7.2.1.1. Target Artery Instability (TAI)
7.2.1.2. Access Artery Injury (AAI)
7.2.1.3. Peripheral Arterial Disease
7.2.1.4. Arteriovenous Fistulas
7.2.1.5. Peripheral Aneurysms
7.2.1.6. Others
7.3. Europe Peripheral Vascular Devices Market Outlook, by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Carotid Artery
7.3.1.2. Fem-Pop Artery
7.3.1.3. Iliac Artery
7.3.1.4. Infrapop Artery
7.4. Europe Peripheral Vascular Devices Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.4.1. Key Highlights
7.4.1.1. Hospitals
7.4.1.2. Ambulatory Surgical Centers/Outpatients
7.4.1.3. Cardiac Catheterization Labs
7.5. Europe Peripheral Vascular Devices Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.5.1. Key Highlights
7.5.1.1. Germany Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.5.1.2. Germany Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.5.1.3. Germany Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.5.1.4. Germany Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.5.1.5. U.K. Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.5.1.6. U.K. Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.5.1.7. U.K. Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.5.1.8. U.K. Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.5.1.9. France Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.5.1.10. France Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.5.1.11. France Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.5.1.12. France Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.5.1.13. Italy Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.5.1.14. Italy Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.5.1.15. Italy Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.5.1.16. Italy Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.5.1.17. Turkey Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.5.1.18. Turkey Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.5.1.19. Turkey Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.5.1.20. Turkey Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.5.1.21. Russia Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.5.1.22. Russia Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.5.1.23. Russia Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.5.1.24. Russia Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.5.1.25. Rest of Europe Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.5.1.26. Rest of Europe Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.5.1.27. Rest of Europe Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.5.1.28. Rest of Europe Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.5.2. BPS Analysis/Market Attractiveness Analysis
8. Asia Pacific Peripheral Vascular Devices Market Outlook, 2018 - 2031
8.1. Asia Pacific Peripheral Vascular Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Peripheral Vascular Stents
8.1.1.1.1. Self-Expanding Stents
8.1.1.1.2. Balloon Expanding Stents
8.1.1.1.3. Covered Stents
8.1.1.1.4. Drug Eluting Stents
8.1.1.2. Drug Eluting Balloons
8.1.1.3. Peripheral Vascular Bioresorbable Scaffolds
8.2. Asia Pacific Peripheral Vascular Devices Market Outlook, by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Target Artery Instability (TAI)
8.2.1.2. Access Artery Injury (AAI)
8.2.1.3. Peripheral Arterial Disease
8.2.1.4. Arteriovenous Fistulas
8.2.1.5. Peripheral Aneurysms
8.2.1.6. Others
8.3. Asia Pacific Peripheral Vascular Devices Market Outlook, by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. Carotid Artery
8.3.1.2. Fem-Pop Artery
8.3.1.3. Iliac Artery
8.3.1.4. Infrapop Artery
8.4. Asia Pacific Peripheral Vascular Devices Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.4.1. Key Highlights
8.4.1.1. Hospitals
8.4.1.2. Ambulatory Surgical Centers/Outpatients
8.4.1.3. Cardiac Catheterization Labs
8.5. Asia Pacific Peripheral Vascular Devices Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.5.1. Key Highlights
8.5.1.1. China Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.5.1.2. China Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.5.1.3. China Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.5.1.4. China Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.5.1.5. Japan Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.5.1.6. Japan Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.5.1.7. Japan Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.5.1.8. Japan Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.5.1.9. South Korea Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.5.1.10. South Korea Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.5.1.11. South Korea Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.5.1.12. South Korea Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.5.1.13. India Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.5.1.14. India Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.5.1.15. India Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.5.1.16. India Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.5.1.17. Southeast Asia Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.5.1.18. Southeast Asia Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.5.1.19. Southeast Asia Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.5.1.20. Southeast Asia Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.5.1.21. Rest of Asia Pacific Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.5.1.22. Rest of Asia Pacific Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.5.1.23. Rest of Asia Pacific Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.5.1.24. Rest of Asia Pacific Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.5.2. BPS Analysis/Market Attractiveness Analysis
9. Latin America Peripheral Vascular Devices Market Outlook, 2018 - 2031
9.1. Latin America Peripheral Vascular Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.1.1. Key Highlights
9.1.1.1. Peripheral Vascular Stents
9.1.1.1.1. Self-Expanding Stents
9.1.1.1.2. Balloon Expanding Stents
9.1.1.1.3. Covered Stents
9.1.1.1.4. Drug Eluting Stents
9.1.1.2. Drug Eluting Balloons
9.1.1.3. Peripheral Vascular Bioresorbable Scaffolds
9.2. Latin America Peripheral Vascular Devices Market Outlook, by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.2.1. Key Highlights
9.2.1.1. Target Artery Instability (TAI)
9.2.1.2. Access Artery Injury (AAI)
9.2.1.3. Peripheral Arterial Disease
9.2.1.4. Arteriovenous Fistulas
9.2.1.5. Peripheral Aneurysms
9.2.1.6. Others
9.3. Latin America Peripheral Vascular Devices Market Outlook, by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.3.1. Key Highlights
9.3.1.1. Carotid Artery
9.3.1.2. Fem-Pop Artery
9.3.1.3. Iliac Artery
9.3.1.4. Infrapop Artery
9.4. Latin America Peripheral Vascular Devices Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.4.1. Key Highlights
9.4.1.1. Hospitals
9.4.1.2. Ambulatory Surgical Centers/Outpatients
9.4.1.3. Cardiac Catheterization Labs
9.5. Latin America Peripheral Vascular Devices Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.5.1. Key Highlights
9.5.1.1. Brazil Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.5.1.2. Brazil Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.5.1.3. Brazil Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.5.1.4. Brazil Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.5.1.5. Mexico Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.5.1.6. Mexico Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.5.1.7. Mexico Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.5.1.8. Mexico Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.5.1.9. Argentina Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.5.1.10. Argentina Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.5.1.11. Argentina Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.5.1.12. Argentina Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.5.1.13. Rest of Latin America Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.5.1.14. Rest of Latin America Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.5.1.15. Rest of Latin America Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.5.1.16. Rest of Latin America Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.5.2. BPS Analysis/Market Attractiveness Analysis
10. Middle East & Africa Peripheral Vascular Devices Market Outlook, 2018 - 2031
10.1. Middle East & Africa Peripheral Vascular Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.1.1. Key Highlights
10.1.1.1. Peripheral Vascular Stents
10.1.1.1.1. Self-Expanding Stents
10.1.1.1.2. Balloon Expanding Stents
10.1.1.1.3. Covered Stents
10.1.1.1.4. Drug Eluting Stents
10.1.1.2. Drug Eluting Balloons
10.1.1.3. Peripheral Vascular Bioresorbable Scaffolds
10.2. Middle East & Africa Peripheral Vascular Devices Market Outlook, by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.2.1. Key Highlights
10.2.1.1. Target Artery Instability (TAI)
10.2.1.2. Access Artery Injury (AAI)
10.2.1.3. Peripheral Arterial Disease
10.2.1.4. Arteriovenous Fistulas
10.2.1.5. Peripheral Aneurysms
10.2.1.6. Others
10.3. Middle East & Africa Peripheral Vascular Devices Market Outlook, by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.3.1. Key Highlights
10.3.1.1. Carotid Artery
10.3.1.2. Fem-Pop Artery
10.3.1.3. Iliac Artery
10.3.1.4. Infrapop Artery
10.4. Middle East & Africa Peripheral Vascular Devices Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.4.1. Key Highlights
10.4.1.1. Hospitals
10.4.1.2. Ambulatory Surgical Centers/Outpatients
10.4.1.3. Cardiac Catheterization Labs
10.5. Middle East & Africa Peripheral Vascular Devices Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.5.1. Key Highlights
10.5.1.1. GCC Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.5.1.2. GCC Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.5.1.3. GCC Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.5.1.4. GCC Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.5.1.5. South Africa Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.5.1.6. South Africa Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.5.1.7. South Africa Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.5.1.8. South Africa Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.5.1.9. Egypt Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.5.1.10. Egypt Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.5.1.11. Egypt Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.5.1.12. Egypt Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.5.1.13. Nigeria Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.5.1.14. Nigeria Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.5.1.15. Nigeria Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.5.1.16. Nigeria Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.5.1.17. Rest of Middle East & Africa Peripheral Vascular Devices Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.5.1.18. Rest of Middle East & Africa Peripheral Vascular Devices Market by Indication, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.5.1.19. Rest of Middle East & Africa Peripheral Vascular Devices Market by Artery, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.5.1.20. Rest of Middle East & Africa Peripheral Vascular Devices Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.5.2. BPS Analysis/Market Attractiveness Analysis
11. Competitive Landscape
11.1. Product vs Indication Heatmap
11.2. Company Market Share Analysis, 2023
11.3. Competitive Dashboard
11.4. Company Profiles
11.4.1. Abbott Laboratories
11.4.1.1. Company Overview
11.4.1.2. Product Portfolio
11.4.1.3. Financial Overview
11.4.1.4. Business Strategies and Development
11.4.2. Boston Scientific Corporation
11.4.2.1. Company Overview
11.4.2.2. Product Portfolio
11.4.2.3. Financial Overview
11.4.2.4. Business Strategies and Development
11.4.3. Cook Medical Inc.
11.4.3.1. Company Overview
11.4.3.2. Product Portfolio
11.4.3.3. Financial Overview
11.4.3.4. Business Strategies and Development
11.4.4. MicroPort Scientific Corporation (Endovastec™)
11.4.4.1. Company Overview
11.4.4.2. Product Portfolio
11.4.4.3. Financial Overview
11.4.4.4. Business Strategies and Development
11.4.5. Medtronic Plc.
11.4.5.1. Company Overview
11.4.5.2. Product Portfolio
11.4.5.3. Financial Overview
11.4.5.4. Business Strategies and Development
11.4.6. Cardinal Health, Inc
11.4.6.1. Company Overview
11.4.6.2. Product Portfolio
11.4.6.3. Financial Overview
11.4.6.4. Business Strategies and Development
11.4.7. B. Braun Melsungen AG
11.4.7.1. Company Overview
11.4.7.2. Product Portfolio
11.4.7.3. Financial Overview
11.4.7.4. Business Strategies and Development
11.4.8. BIOTRONIK SE & Co. KG
11.4.8.1. Company Overview
11.4.8.2. Product Portfolio
11.4.8.3. Financial Overview
11.4.8.4. Business Strategies and Development
11.4.9. Becton, Dickinson, and Company
11.4.9.1. Company Overview
11.4.9.2. Product Portfolio
11.4.9.3. Financial Overview
11.4.9.4. Business Strategies and Development
11.4.10. W. L. Gore & Associates Inc.
11.4.10.1. Company Overview
11.4.10.2. Product Portfolio
11.4.10.3. Financial Overview
11.4.10.4. Business Strategies and Development
11.4.11. Getinge AB
11.4.11.1. Company Overview
11.4.11.2. Product Portfolio
11.4.11.3. Financial Overview
11.4.11.4. Business Strategies and Development
11.4.12. Terumo Corp
11.4.12.1. Company Overview
11.4.12.2. Product Portfolio
11.4.12.3. Financial Overview
11.4.12.4. Business Strategies and Development
11.4.13. Kyoto Medical Planning Co Ltd
11.4.13.1. Company Overview
11.4.13.2. Product Portfolio
11.4.13.3. Financial Overview
11.4.13.4. Business Strategies and Development
11.4.14. iVascular S.L.U
11.4.14.1. Company Overview
11.4.14.2. Product Portfolio
11.4.14.3. Financial Overview
11.4.14.4. Business Strategies and Development
11.4.15. AMG International GmbH
11.4.15.1. Company Overview
11.4.15.2. Product Portfolio
11.4.15.3. Financial Overview
11.4.15.4. Business Strategies and Development
11.4.16. Endocor GmbH
11.4.16.1. Company Overview
11.4.16.2. Product Portfolio
11.4.16.3. Financial Overview
11.4.16.4. Business Strategies and Development
11.4.17. Meril Life Sciences Pvt. Ltd.
11.4.17.1. Company Overview
11.4.17.2. Product Portfolio
11.4.17.3. Financial Overview
11.4.17.4. Business Strategies and Development
11.4.18. Nano Therapeutics Pvt Ltd
11.4.18.1. Company Overview
11.4.18.2. Product Portfolio
11.4.18.3. Financial Overview
11.4.18.4. Business Strategies and Development
11.4.19. Koninklijke Philips N.V.
11.4.19.1. Company Overview
11.4.19.2. Product Portfolio
11.4.19.3. Financial Overview
11.4.19.4. Business Strategies and Development
11.4.20. REVA Medical
11.4.20.1. Company Overview
11.4.20.2. Product Portfolio
11.4.20.3. Financial Overview
11.4.20.4. Business Strategies and Development
12. Appendix
12.1. Research Methodology
12.2. Report Assumptions
12.3. Acronyms and Abbreviations

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Cook Medical Inc.
  • MicroPort Scientific Corporation (Endovastec™)
  • Medtronic Plc.
  • Cardinal Health, Inc.
  • B. Braun Melsungen AG
  • BIOTRONIK SE & Co. KG
  • Becton, Dickinson, and Company
  • W. L. Gore & Associates Inc.
  • Getinge AB
  • Terumo Corp
  • Kyoto Medical Planning Co Ltd
  • iVascular S.L.U
  • AMG International GmbH
  • ENDOCOR GmbH
  • Meril Life Sciences Pvt. Ltd.
  • Nano Therapeutics Pvt Ltd
  • Koninklijke Philips N.V.
  • REVA Medical

Methodology

Loading
LOADING...